HRA000708
Title:
Association between NR3C1 mutations and glucocorticoid resistance in children with acute lymphoblastic leukemia
Release date:
2021-07-30
Description:
The outcome of patients with relapsed/refractory ALL remains unsatisfactory, despite these patients generally receive more intense therapy. Glucocorticoid (GC) resistance is a leading cause of treatment failure and relapse in ALL. Abnormal NR3C1 transcription and/or translation are strongly associated with GC resistance, but the underlying molecular mechanism and the clinical value of NR3C1 alterations with GC resistance in ALL treatment remain unclear.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
acute lymphocytic leukemia
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
HUI ZHANG
Contact person:
ZHANG HUI
Email:
zhanghuirjh@gwcmc.org
Description:
Take the responsibility of data access and approval for external use.
Individuals & samples
Submitter:   ZHANG HUI / zhanghuirjh@gwcmc.org
Organization:   Guangzhou women and children‘s medical center
Submission date:   2020-11-30
Requests:   1